[Stability of the toxoplasmin tests in patients treated with immunosuppressive agents].
D000328:Adult; D000941:Antigens; D000970:Antineoplastic Agents / Q000627:therapeutic use; D003168:Complement Fixation Tests; D005188:False Negative Reactions; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D007153:Immunologic Deficiency Syndromes; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D012882:Skin Tests; D014123:Toxoplasmosis / Q000276:immunology*
D000941:Antigens; D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; D011241:Prednisone
Zur Stabilität des Toxoplasmintestes bei immunsuppressiv behandelten Patienten.